Protagenic Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Protagenic Therapeutics (PTIX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Protagenic Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagenic Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagenic Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $60k | 15k | 4.00 |